188 related articles for article (PubMed ID: 35398042)
1. The Association Between Proton Pump Inhibitor Exposure and Key Liver-Related Outcomes in Patients With Cirrhosis: A Veterans Affairs Cohort Study.
Mahmud N; Serper M; Taddei TH; Kaplan DE
Gastroenterology; 2022 Jul; 163(1):257-269.e6. PubMed ID: 35398042
[TBL] [Abstract][Full Text] [Related]
2. Proton Pump Inhibitor Utilization in Veteran Patients on Combined Antithrombotic Therapy and Validation of Simplified Bleeding Risk Score.
Patil T; Murphy K; Woodard L; Lebrecht M
Pharmacotherapy; 2020 Dec; 40(12):1219-1227. PubMed ID: 33073362
[TBL] [Abstract][Full Text] [Related]
3. Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis.
De Roza MA; Kai L; Kam JW; Chan YH; Kwek A; Ang TL; Hsiang JC
World J Gastroenterol; 2019 Sep; 25(33):4933-4944. PubMed ID: 31543684
[TBL] [Abstract][Full Text] [Related]
4. Statin exposure is associated with reduced development of acute-on-chronic liver failure in a Veterans Affairs cohort.
Mahmud N; Chapin S; Goldberg DS; Reddy KR; Taddei TH; Kaplan DE
J Hepatol; 2022 May; 76(5):1100-1108. PubMed ID: 35066085
[TBL] [Abstract][Full Text] [Related]
5. Deleterious effect of proton pump inhibitors on the disease course of cirrhosis.
Janka T; Tornai T; Borbély B; Tornai D; Altorjay I; Papp M; Vitális Z
Eur J Gastroenterol Hepatol; 2020 Feb; 32(2):257-264. PubMed ID: 31464790
[TBL] [Abstract][Full Text] [Related]
6. Risk of death among users of Proton Pump Inhibitors: a longitudinal observational cohort study of United States veterans.
Xie Y; Bowe B; Li T; Xian H; Yan Y; Al-Aly Z
BMJ Open; 2017 Jul; 7(6):e015735. PubMed ID: 28676480
[TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitors are associated with accelerated development of cirrhosis, hepatic decompensation and hepatocellular carcinoma in noncirrhotic patients with chronic hepatitis C infection: results from ERCHIVES.
Li DK; Yan P; Abou-Samra AB; Chung RT; Butt AA
Aliment Pharmacol Ther; 2018 Jan; 47(2):246-258. PubMed ID: 29105111
[TBL] [Abstract][Full Text] [Related]
8. Proton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated cirrhosis.
Bajaj JS; Ratliff SM; Heuman DM; Lapane KL
Aliment Pharmacol Ther; 2012 Nov; 36(9):866-74. PubMed ID: 22966967
[TBL] [Abstract][Full Text] [Related]
9. Proton pump inhibitor intake neither predisposes to spontaneous bacterial peritonitis or other infections nor increases mortality in patients with cirrhosis and ascites.
Mandorfer M; Bota S; Schwabl P; Bucsics T; Pfisterer N; Summereder C; Hagmann M; Blacky A; Ferlitsch A; Sieghart W; Trauner M; Peck-Radosavljevic M; Reiberger T
PLoS One; 2014; 9(11):e110503. PubMed ID: 25369194
[TBL] [Abstract][Full Text] [Related]
10. Time-Varying Use of Proton Pump Inhibitors and Cognitive Impairment and Dementia: A Real-World Analysis from Germany.
Ahn N; Wawro N; Baumeister SE; Nolde M; Gerlach R; Tauscher M; Günter A; Güntner F; Rückert-Eheberg IM; Meisinger C; Linseisen J
Drugs Aging; 2023 Jul; 40(7):653-663. PubMed ID: 37178361
[TBL] [Abstract][Full Text] [Related]
11. The Association Between Homelessness and Key Liver-Related Outcomes in Veterans With Cirrhosis.
Pulaski M; Bittermann T; Taddei TH; Kaplan DE; Mahmud N
Am J Gastroenterol; 2024 Feb; 119(2):297-305. PubMed ID: 37782293
[TBL] [Abstract][Full Text] [Related]
12. Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study.
Ray WA; Murray KT; Griffin MR; Chung CP; Smalley WE; Hall K; Daugherty JR; Kaltenbach LA; Stein CM
Ann Intern Med; 2010 Mar; 152(6):337-45. PubMed ID: 20231564
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular and gastrointestinal events of three antiplatelet therapies: clopidogrel, clopidogrel plus proton-pump inhibitors, and aspirin plus proton-pump inhibitors in patients with previous gastrointestinal bleeding.
Tsai YW; Wen YW; Huang WF; Chen PF; Kuo KN; Hsiao FY
J Gastroenterol; 2011 Jan; 46(1):39-45. PubMed ID: 20811753
[TBL] [Abstract][Full Text] [Related]
14. Proton pump inhibitor treatment is associated with acute-on-chronic liver failure in patients with advanced cirrhosis.
Sturm L; Gahm C; Schultheiss M; Reincke M; Huber JP; Boettler T; Thimme R; Bettinger D
Hepatol Commun; 2023 Jul; 7(7):. PubMed ID: 37347229
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of proton-pump inhibitor against gastrointestinal bleeding in patients receiving oral anticoagulants: A systematic review and meta-analysis.
Ahn HJ; Lee SR; Choi EK; Rhee TM; Kwon S; Oh S; Lip GYH
Br J Clin Pharmacol; 2022 Nov; 88(11):4676-4687. PubMed ID: 35921204
[TBL] [Abstract][Full Text] [Related]
16. Association of Proton Pump Inhibitors With Reduced Risk of Warfarin-Related Serious Upper Gastrointestinal Bleeding.
Ray WA; Chung CP; Murray KT; Smalley WE; Daugherty JR; Dupont WD; Stein CM
Gastroenterology; 2016 Dec; 151(6):1105-1112.e10. PubMed ID: 27639805
[TBL] [Abstract][Full Text] [Related]
17. Impact of Proton Pump Inhibitor Use on the Comparative Effectiveness and Safety of Prasugrel Versus Clopidogrel: Insights From the Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE-ACS) Study.
Jackson LR; Peterson ED; McCoy LA; Ju C; Zettler M; Baker BA; Messenger JC; Faries DE; Effron MB; Cohen DJ; Wang TY
J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27792656
[TBL] [Abstract][Full Text] [Related]
18. Do proton pump inhibitors increase mortality? A systematic review and in-depth analysis of the evidence.
Ben-Eltriki M; Green CJ; Maclure M; Musini V; Bassett KL; Wright JM
Pharmacol Res Perspect; 2020 Oct; 8(5):e00651. PubMed ID: 32996701
[TBL] [Abstract][Full Text] [Related]
19. Prevention of Dabigatran-Related Gastrointestinal Bleeding With Gastroprotective Agents: A Population-Based Study.
Chan EW; Lau WC; Leung WK; Mok MT; He Y; Tong TS; Wong IC
Gastroenterology; 2015 Sep; 149(3):586-95.e3. PubMed ID: 25960019
[TBL] [Abstract][Full Text] [Related]
20. Proton Pump Inhibitors Increases Longitudinal Risk of Mortality, Decompensation, and Infection in Cirrhosis: A Meta-Analysis.
Wong ZY; Koh JH; Muthiah M; Koh B; Ong EYH; Ong CEY; Ou KQ; Lim WH; Tan DJH; Chee D; Siah KTH; Wong Y; Kaewdech A; Wijarnpreecha K; Kulkarni AV; Nah B; Huang DQ; Noureddin M; Ng CH; Teng M
Dig Dis Sci; 2024 Jan; 69(1):289-297. PubMed ID: 37968557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
